Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Silco Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 3, 2026	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,360	1,754	2,533	2,741	2,709	2,325
Market Cap Growth	-18.13%	-30.74%	-7.58%	1.15%	16.52%	0.16%
Enterprise Value	1,332	1,703	2,491	2,643	2,599	2,064
Last Close Price	13.10	16.66	23.75	25.15	23.90	19.62
PE Ratio	-	38.24	36.59	32.45	32.01	27.96
PS Ratio	-	4.28	5.45	4.90	4.51	3.17
PB Ratio	0.57	0.75	1.09	1.20	1.20	1.03
P/TBV Ratio	0.57	0.75	1.09	1.20	1.20	1.03
P/FCF Ratio	-	32375.63	-	43.53	-	-
P/OCF Ratio	-	20.81	14.03	16.21	10.53	15.86
EV/Sales Ratio	-	4.15	5.36	4.72	4.32	2.81
EV/EBITDA Ratio	-	11.52	16.19	15.35	16.88	11.75
EV/EBIT Ratio	-	28.78	37.09	27.12	32.74	21.29
EV/FCF Ratio	-	31423.90	-	41.99	-	-
Debt / Equity Ratio	0.00	0.00	-	0.00	0.00	-
Debt / EBITDA Ratio	-	0.06	-	0.02	0.05	-
Debt / FCF Ratio	-	176.56	-	0.07	-	-
Net Debt / Equity Ratio	-0.01	-0.01	-0.02	-0.03	-0.03	-0.11
Net Debt / EBITDA Ratio	-	-0.14	-0.32	-0.35	-0.42	-1.47
Net Debt / FCF Ratio	-	-385.79	33.89	-0.96	0.54	11.00
Asset Turnover	-	0.15	0.17	0.21	0.23	0.28
Inventory Turnover	-	0.63	0.71	0.82	0.96	1.19
Quick Ratio	2.11	1.45	1.45	1.56	1.64	2.86
Current Ratio	4.73	3.39	3.40	3.61	3.72	5.10
Return on Equity (ROE)	-	1.96%	3.01%	3.72%	3.75%	3.76%
Return on Assets (ROA)	-	1.32%	1.53%	2.25%	1.85%	2.32%
Return on Invested Capital (ROIC)	-	1.98%	2.32%	3.42%	3.57%	3.76%
Return on Capital Employed (ROCE)	-	2.40%	2.70%	4.00%	3.30%	4.00%
Earnings Yield	-	2.61%	2.73%	3.08%	3.12%	3.58%
FCF Yield	-	0.00%	-0.06%	2.30%	-4.40%	-1.01%
Dividend Yield	0.85%	0.60%	1.26%	1.99%	4.18%	5.10%
Payout Ratio	-	41.72%	45.43%	74.15%	73.25%	22.11%
Buyback Yield / Dilution	2.36%	-	-	-	-	-28.88%
Total Shareholder Return	3.13%	0.60%	1.26%	1.99%	4.18%	-23.78%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.